D-Wave Quantum’s First Investor Day Arrives Amid Scientific Validation, $100M CHIPS Act Prospects and Record?Breaking Bookings

D-Wave Quantum is heading into its inaugural investor day on Monday with no shortage of narrative fuel. The quantum?computing company has spent the last month juggling a defence of its scientific credibility, a potential $100 million injection from the CHIPS and Science Act, and an eye?popping 1,994% year?on?year leap in first?quarter bookings. All of that lands as the stock sits just above €25, a level that has turned into a critical technical battleground.

The event, scheduled for June 1 from 1?pm to 4?pm Eastern Time at the New York Stock Exchange, will cover technology leadership, product roadmap, commercial momentum and the long?term growth strategy. The timing, however, is delicate. The same week is packed with US macro releases – the ISM Manufacturing and Services reports, JOLTS data, and the May employment report – any of which could redirect investor attention from quantum narratives to earnings visibility and cash?burn rates.

Government Money and Scientific Credentials

Behind the near?term catalyst lies a deeper story of public backing. In May, D?Wave signed a non?binding memorandum of understanding with the US Department of Commerce that could unlock up to $100 million from the CHIPS and Science Act. In exchange, the government would receive an equity stake through newly issued shares. The funds are earmarked for a planned research centre in Boca Raton and for developing an annealing quantum system with 100,000 qubits and a gate?model system with 10,000 qubits. The agreement has not yet been finalised.

Separately, the Northeast Regional Defense Technology Hub (NORDTECH) awarded D?Wave funding for the second year of the Microelectronics Commons Project, which targets scalable superconducting qubit fabrication and materials research for both commercial and defence applications.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

On the scientific front, D?Wave reinforced the validity of its quantum?supremacy demonstration published in Science on March 12. On May 26 the company stated that the BP?TNS algorithm from the Flatiron Institute does not replicate the full scope of its demonstration, particularly on the hardest 3D and biclique problem regimes. The rebuttal is crucial for maintaining investor confidence in the company’s technological edge.

Bookings Explosion vs. Revenue Recognition

The most eye?catching fundamental metric comes from Q1 2026: D?Wave reported bookings of $33.4 million, a 1,994% year?over?year surge. Yet reported revenue slid to $2.9 million from $15.0 million a year earlier. The gap highlights the lag between contract wins and revenue recognition – a dynamic that will inevitably dominate questions from investors. Remaining performance obligations stood at $42.4 million at the end of March, of which about 54% is expected to convert to revenue within twelve months.

The company finished the quarter with $588.4 million in cash and marketable securities, but also posted a net loss of $18.4 million and an adjusted EBITDA loss of $32.8 million. The cash pile provides a long runway, but the direction of cash burn and the speed of conversion from bookings to recognised revenue will be key themes at Monday’s presentation.

Stock in a Volatile Setup

The shares closed on Friday at €25.80, having more than doubled from the 52?week low of €11.32 in March. The intraday range on Friday was €23.60 to €26.00, giving momentum traders a near?term reference. The stock trades 52.5% above its 50?day moving average and 26.2% above its 200?day average, while still sitting 33% below the 52?week high of €38.48. Annualised 30?day volatility stands at 134%.

Short interest adds an extra layer of drama. As of May 15, 50.34 million shares were shorted, representing a short?to?float ratio of 14.11%. If Monday’s presentation delivers concrete roadmap details and bolsters confidence in the commercial trajectory, that short book could fuel a squeeze. If the event disappoints, the same positioning could accelerate profit?taking after the recent rally.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

Nine analysts cover the stock with a consensus of “Moderate Buy” and an average target of $34.67, implying about 15% upside from last US close of $30.07.

Broader Sector Tailwind

D?Wave is not alone in riding a wave of public?sector enthusiasm. Late May saw a rally in listed quantum stocks after the US government announced a $2 billion programme to support the sector, with plans for roughly $100 million equity investments in a range of startups. The sentiment boost is welcome in an industry where current revenues remain modest but long?term expectations continue to climb.

For D?Wave, the coming week is less about a single headline and more about confirmation. The market has already priced the stock back into the €25 zone. Now investors are looking for evidence that the roadmap details, hardware demand, AI?use cases and macro conditions can sustain that valuation into June and beyond.

Ad

D-Wave Quantum Stock: New Analysis - 31 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | D-WAVE | boerse | 69454496 |